FTC Appoints Endo Pay-For-Delay Settlement Monitor
The Federal Trade Commission on Tuesday approved a monitor to oversee future agreements related to Endo Pharmaceuticals' resolution of agency claims that it used pay-for-delay settlements to block consumers' access to...To view the full article, register now.
Already a subscriber? Click here to view full article